Referanslar

1. Suchocka Z, Swatowska J, Pachecka J, Suchocka P; RP-HPLC determination of Paraoxonase activity in human blood serum; J of Pharmaceutical and Biomedical Analysis  2006;  42:113-119

2. Marchegiani F, Marra M, Olivieri F, Cardelli M, James RW, Boemi M, Franceschi C.   Paraoxonase 1: genetics and activities during aging. Rejuvenation Res. 2008 Mar;11(1):113-27.

3. Hofer  Hofer SE, Bennetts B, Chan AK, Holloway B, Karschimkus C, Jenkins AJ, Silink M, Donaghue KC. Association between PON 1 polymorphisms, PON activity and diabetes complications. J Diabetes Complications. 2006 20(5):322 -8.

4. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis. 1991; 86(2-3):193-9.

5. Horoz M, Aslan M, Selek S, Koylu AO, Bolukbas C, Bolukbas FF, Celik H, Erel O.   PON1 status in haemodialysis patients and the impact of hepatitis C infection. Clin Biochem. 2007;40(9-10):609-14.

6. Gur M, Aslan M, Yildiz A, Demirbag R, Yilmaz R, Selek S, Erel O, Ozdogru I.  Paraoxonase and arylesterase activities in coronary artery disease. Eur J Clin Invest. 2006 Nov;36(11):779-87.

7. Aslan M, Kosecik M, Horoz M, Selek S, Celik H, Erel O. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis. 2007 Apr;191(2):397-402.

8. Aslan M, Nazligul Y, Horoz M, Bolukbas C, Bolukbas FF, Gur M, Celik H, Erel O.  Serum paraoxonase-1 activity in Helicobacter pylori infected subjects. Atherosclerosis. 2008 Jan;19 6(1):270-4.